Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland

International Journal of Drug Policy

Volumn 23, Issue 5, 2012, Pages 346-352

  Allen, Elizabeth J ^a   Palmateer, Norah E ^b   Hutchinson, Sharon J ^b,c   Cameron, Sheila ^d   Goldberg, David J ^b   Taylor, Avril ^a  

^a UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

^b HEALTH PROTECTION SCOTLAND   (United Kingdom)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^d GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

Hepatitis C virus; Injection equipment; Methadone; Recent infection

Indexed keywords

HEPATITIS C ANTIBODY; METHADONE; VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH SERVICE; HEALTH SURVEY; HEPATITIS C; HUMAN; INCIDENCE; INSTRUMENT STERILIZATION; INTERVENTION STUDY; INTRAVENOUS DRUG ABUSE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NEEDLE; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PRIORITY JOURNAL; RISK REDUCTION; SELF REPORT; SYRINGE; UNITED KINGDOM; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HARM REDUCTION; HEPATITIS C; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; METHADONE; NEEDLE-EXCHANGE PROGRAMS; OPIATE SUBSTITUTION TREATMENT; PREVALENCE; QUESTIONNAIRES; SCOTLAND; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84866145721     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2012.07.006     Document Type: Article

References (33)

1. Arasteh K., Des Jarlais D.C. At-risk drinking and injection and sexual risk behaviors of HIV-positive injection drug users entering drug treatment in New York City. Aids Patient Care and STDS 2009, 23:657-661.
2. Bennett S., Gunson R.N., McAllister G.E., Cameron S.O., Carman W.F. Detection of hepatitis C virus RNA in dried blood spots. Journal of Clinical Virology 2012, 54:106-109.
3. Bryant J., Hopwood M. Secondary exchange of sterile injecting equipment in a high distribution environment: A mixed method analysis in south east Sydney, Australia. International Journal of Drug Policy 2009, 20:324-328.
4. Champion J.K., Taylor A., Hutchinson S., Cameron S., McMenamin J., Mitchell A., et al. Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: A cohort study. American Journal of Epidemiology 2004, 159:514-519.
5. Craine N., Hickman M., Parry J.V., Smith J., Walker A.M., Russell D., et al. Incidence of hepatitis C in drug injectors: The role of homelessness, opiate substitution treatment, equipment sharing, and community size. Epidemiology and Infection 2009, 137:1255-1265.
6. European Centre for Disease Prevention and Control Evidence for the effectiveness of interventions to prevent infections among people who inject drugs. Part 1: Needle and syringe programmes and other interventions for preventing hepatitis C, HIV and injecting risk behaviour 2011, ECDC, Stockholm.
7. Glynn S.A., Wright D.J., Kleinman S.H., Hirschkorn D., Tu Y., Heldebrant C., et al. Dynamics of viremia in early hepatitis C virus infection. Transfusion 2005, 45:994-1002.
8. Health Protection Scotland and University of the West of Scotland The Needle Exchange Surveillance Initiative (NESI): Prevalence of HCV and injecting risk behaviours among injecting drug users attending needle exchanges in Scotland, 2007 2008, Health Protection Scotland, Glasgow.
9. Hope V.D., Hickman M., Ngui S.L., Jones S., Telfer M., Bizzarri M., et al. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. Journal of Viral Hepatitis 2011, 18:262-270.
10. Hutchinson S.J., McIntyre P.G., Molyneaux P., Cameron S., Burns S., Taylor A., et al. Prevalence of hepatitis C among injectors in Scotland 1989-2000: Declining trends among young injectors halt in the late 1990s. Epidemiology and Infection 2002, 128:473-477.
11. ISD Scotland Injecting Equipment Provision in Scotland Survey 2008/09 2010, NHS National Services Scotland, Edinburgh.
12. ISD Scotland Injecting Equipment Provision in Scotland Survey 2009/10 2011, NHS National Services Scotland, Edinburgh.
13. Judd A., Hickman M., Jones S., McDonald T., Parry J.V., Stimson G.V., et al. Incidence of hepatitis C virus and HIV among new injecting drug users in London: Prospective cohort study. BMJ 2005, 330:24-25.
14. Judd A., Parry J., Hickman M., McDonald T., Jordan L., Lewis K., et al. Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. Journal of Medical Virology 2003, 71:49-55.
15. Lenton S., Bevan J., Lamond T. Threat or opportunity? Secondary exchange in a setting with widespread availability of needles. Substance Use and Misuse 2006, 41:845-864.
16. Lurie P. Invited commentary: Le mystere de Montreal. American Journal of Epidemiology 1997, 146:1003-1006.
17. Maher L., Jalaludin B., Chant K.G., Jayasuriya R., Sladden T., Kaldor J.M., et al. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction 2006, 101:1499-1508.
18. McDonald, S. A., Hutchinson, S. J., Cameron, S. O., Innes, H. A., McLeod, A., & Goldberg, D. J. (2012). Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow. International Journal of Drug Policy, doi:10.1016/j.drupo.2012.02.003.
19. Netski D.M., Mosbruger T., Depla E., Maertens G., Ray S.C., Hamilton R.G., et al. Humoral immune response in acute hepatitis C virus infection. Clinical Infectious Diseases 2005, 41:667-675.
20. Page-Shafer K., Pappalardo B.L., Tobler L.H., Phelps B.H., Edlin B.R., Moss A.R., et al. Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. Journal of Clinical Microbiology 2008, 46:499-506.
21. Palmateer N., Kimber J., Hickman M., Hutchinson S., Rhodes T., Goldberg D. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: A review of reviews. Addiction 2010, 105:844-859.
22. Roy K.M., Hutchinson S.J., Wadd S., Taylor A., Cameron S.O., Burns S., et al. Hepatitis C virus infection among injecting drug users in Scotland: A review of prevalence and incidence data and the methods used to generate them. Epidemiology and Infection 2007, 135:433-442.
23. Sander P.M., Cole S.R., Ostrow D.G., Mehta S.H., Kirk G.D. Determinants of alcohol consumption in HIV-uninfected injection drug users. Drug and Alcohol Dependence 2010, 111:173-176.
24. Scottish Government Hepatitis C action plan for Scotland, phase II (May 2008-March 2011) 2008, Scottish Government, Edinburgh.
25. Taylor A., Goldberg D., Hutchinson S., Cameron S., Gore S.M., McMenamin J., et al. Prevalence of Hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: Are current harm reduction strategies working?. Journal of Infection 2000, 40:176-183.
26. Thomson E.C., Nastoulia E., Main J., Karayiannis P., Eliahoo J., Muir D., et al. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS 2009, 23:89-93.
27. Thomson E.C., Smith J.A., Klenerman P. The natural history of early hepatitis C virus evolution; lessons from a global outbreak in human immunodeficiency virus-1-infected individuals. Journal of General Virology 2011, 92:2227-2236.
28. Thorpe L.E., Ouellet L.J., Hershow R., Bailey S.L., Williams I.T., Williamson J., et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. American Journal of Epidemiology 2002, 155:645-653.
29. Turner K., Hutchinson S., Vickerman P., Hope V., Craine N., Palmateer N., et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of Hepatitis C virus in injecting drug users: Pooling of UK evidence. Addiction 2011, 106:1978-1988.
30. University of the West of Scotland, Health Protection Scotland, & West of Scotland Specialist Virology Centre The Needle Exchange Surveillance Initiative (NESI): Prevalence of HCV and injecting risk behaviours among injecting drug users attending needle exchanges in Scotland, 2008/2009 2010, University of the West of Scotland, Paisley.
31. Vallejo R., de Leon-Casasola O., Benyamin R. Opioid therapy and immunosuppression: A review. American Journal of Therapeutics 2004, 11:354-365.
32. Van Den Berg C., Smit C., Van Brussel G., Coutinho R., Prins M. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: Evidence from the Amsterdam Cohort Studies among drug users. Addiction 2007, 102:1454-1462.
33. Vidal-Trécan G., Coste J., Varescon-Pousson I., Reboul-Marty J., Christoforov B., Boissonnas A. Patterns of sexual and injecting risk behaviours in French intravenous drug users not reporting HIV and hepatitis C virus seropositivities. Addiction 1998, 93:1657-1668.